PLX
Protalix Biotherapeutics, Inc.
$2.13-0.03 (-1.39%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Protalix BioTherapeutics, Inc. (PLX) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
Showing 10 of 21 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-23 | 2025-12-19 | Bashan Dror | CEO | Purchase | 56,000 | $1.81 | $101,360 | N/A | N/A |
| 2025-11-19 | 2025-11-18 | Bar-Shalev Amos | Director | Sale | 168 | $1.87 | -$314 | N/A | N/A |
| 2025-09-04 | 2025-09-03 | Bar-Shalev Amos | Director | Award | 7,500 | $0.00 | $0 | N/A | N/A |
| 2025-09-04 | 2025-09-03 | Schwartz Aharon | Director | Award | 7,500 | $0.00 | $0 | N/A | N/A |
| 2025-09-04 | 2025-09-03 | Melincoff Gwen A | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |
| 2025-09-04 | 2025-09-03 | Naos Yaron | VP | Award | 50,000 | $0.00 | $0 | N/A | N/A |
| 2025-09-04 | 2025-09-03 | Ben Zvi Shmuel | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |
| 2025-09-04 | 2025-09-03 | Elze Christian | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |
| 2025-09-04 | 2025-09-03 | Bashan Dror | CEO | Award | 195,000 | $0.00 | $0 | N/A | N/A |
| 2025-09-04 | 2025-09-03 | Bashan Dror | CEO | Award | 340,000 | $0.00 | $0 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.